Du repérage systématique au sevrage tabagique : un nouveau paradigme

Abstract

Lung cancer is the first cause of death by cancer in France with more than 30,000 deaths per year. Smoking cessation is the most effective measure to limit the lung cancer epidemic, but is also an important element in the care of patients with lung cancer regardless of the stage. In localized cancers, the continuation of tobacco is associated with a reduction in survival by increasing the risk of recurrence and of developing a second cancer. In the perioperative period, smoking cessation can limit infectious complications and the length of hospitalisation. Whatever the stage of cancer, weaning improves dyspnea, appetite and reduces asthenia; this results in an improved quality of life. Early identification of the patients smoking should be offered systematically with the aim of early cessation. Early identification and brief intervention are methods allowing any trained caregiver to assess the smoker’s dependence, prescribe nicotine substitute and possibly refer him to a tobacco consultation.1877-1203/© 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.